Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration
Top Cited Papers
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 110 (5) , 979-986
- https://doi.org/10.1016/s0161-6420(03)00085-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of ProteinsEndocrine Reviews, 1992
- Laser Photocoagulation of Subfoveal Neovascular Lesions in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1991
- Argon Laser Photocoagulation for Neovascular MaculopathyArchives of Ophthalmology (1950), 1991
- Krypton Laser Photocoagulation for Neovascular Lesions of Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1990
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Epidemiology of eye disease in the elderlyEye, 1987
- Common causes of blindness and visual handicap in the west of Scotland.British Journal of Ophthalmology, 1983
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983